OHI Company Profile and Key Details

Short-term trend indicators are bearishly aligned (SMA20 5.0%, SMA50 7.16%, SMA200 15.86%). The stock’s 14-day RSI is 67.27 (firm momentum), while the ATR of 0.96 points to higher daily volatility. The stock remains currently trading near 52-week highs, trading 0.31% below its high and over 37.24% above its low. Average 10-day trading volume of 1.43 million shares is below the 3-month average of 2.00 million, indicating normal recent market interest.

Omega Healthcare Investors, Inc. last paid a dividend of 2.69 per share, this equals a trailing yield of roughly 6.61%. Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $68.49. This means the shares are trading below this model’s fair value.

Omega Healthcare Investors, Inc. has 303.01 million shares outstanding. The public float is 302.06 million shares, elevated short interest at 4.26% of float. This equals 12.88 million shares. The short ratio is 6.86 days. Institutional investors hold 82.01% of the float. Insiders own 0.2%. KORMAN BERNARD J holds 996.90 thousand shares, PICKETT C TAYLOR has 934.75 thousand shares and Bernfield Craig M has 860.00 thousand shares.

Omega Healthcare Investors, Inc. generated EPS of $1.93 over the past year. Five-year average earnings growth is 23.4%. Wall Street analysts project EPS growth of 1.4% annually over the next five years. The latest quarter delivered EPS of $1.19. The next quarter is forecast at $0.49. Next year's EPS is expected at $25.54. Analyst sentiment is neutral. Analyst rating data shows there are 6 Strong Buy ratings, 6 Buy ratings, 16 Hold ratings, 0 Sell rating and 2 Strong Sell ratings. Price targets range from $58.00 to $40.00. The high target offers 25.05% upside. The low target suggests -13.76% downside. The mean target is $48.57. This offers 4.72% upside. Omega Healthcare Investors, Inc. earnings surprise history is a consistent trend of beating forecasts. The quarter that ended July 29, 2026, missed forecasts by 133.79%. The prior quarter beat by 67.07%. Over the last six quarters, Apple has recorded several small beats. These include 0.0% in May 01, 2025.

Omega Healthcare Investors, Inc. trades at a P/E ratio of 16.11, slightly below the S&P 500 average, with a price-to-sales ratio of 10.78 and a price-to-book ratio of 2.58 suggesting the stock is closer to book value. The P/FCF stands at 15.42, also above market averages.

Omega Healthcare Investors, Inc. (NYSE:OHI) closed at $46.38 USD, losing -$0.66 (-1.40%) from the previous close of $47.04. The stock is currently mid-range between its 52-week high and low $39.26 and $52.39. With a market capitalization of about $13.87 billion, Omega Healthcare Investors, Inc. is classified as a large-cap and shows lower-than-market volatility (beta ~0.58). Key stats such as the average daily volume over the past year has been around 2.02 million shares, volume is running light vs its 52-week average. Headquartered in Hunt Valley, MD, Omega Healthcare Investors, Inc. operates in the Real Estate sector and the REIT - Healthcare Facilities industry. Led by CEO Charles Taylor Pickett, the company employs approximately 69 people and listed since August 07, 1992. Omega Healthcare Investors, Inc. functions as a Real Estate Investment Trust (REIT) primarily focused on the long-term healthcare sector.

Our AI price prediction model suggests that Omega Healthcare Investors, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 0.99%, with price expected at $46.84 by September 17, 2026, within a range of $45.48 to $48.37 3-Month Outlook: Projected rise of 0.95%, reaching $46.82 by December 02, 2026, with a range of $46.40 to $47.18. 1-Year Outlook: Projected gain of 14.68%, with price at $53.19 by September 03, 2027, within a range of $52.32 to $54.21.

Omega Healthcare Investors, Inc. (NYSE:OHI) shares are flat 1.58% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows Omega Healthcare Investors, Inc. trading at a premium to the broader market with a P/E of 16.11. Analyst sentiment is cautious, with the majority of ratings in Equal-Weight territory and a mean price target of $39.72, suggesting -14.36% downside. Our AI forecast model points to short-term strength (0.99% over two weeks), a medium-term rise (0.95% over three months), and a longer-term gain (14.68% over one year), with expected trading ranges indicating moderate volatility.